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To the Editor: Glycogen storage disease (GSD) is a group of inherited disorders with abnormal glycogen deposition. [1] Pulmonary hypertension (PH) is a rare complication of GSD with unclear etiology. Since the pioneer description in 1980, [2] only a few cases of GSD-associated PH have been reported. Here, we reported a Chinese case with informed consent by the patient and the guardian.
A 16-year-old girl was admitted to China-Japan Friendship Hospital with cyanosis and dyspnea on exertion for 3 months. The patient was found with growth retardation from 5 years of age. She was 153 cm in height and 34 kg in body weight on admission. Physical examination revealed that her skeletal muscles were generally weak and atrophic. On auscultation, an accentuated pulmonic second heart sound was noted. Serum creatine kinase concentration was 238 U/L. Electrocardiogram showed right-axis deviation. Echocardiogram showed right ventricular enlargement and tricuspid regurgitation with systolic pulmonary artery pressure of 65 mmHg (<36 mmHg in normal, 1 mmHg = 0.133 kPa), and no intracardiac shunt was found. The arterial blood gas analysis in room air revealed pH 7.325, PCO 2 83. Figure 1 ]. Genetic analysis revealed compound heterozygous mutations in GAAat.1309C>T (p. R437C) and c.1562A>T (p.E521V). These findings confirmed that the patient had GSD Type II. After treatment with noninvasive positive pressure ventilation, diuretics, antibiotics, and supportive care, she got improved and discharged.
GSD-associated PH is poorly understood. So far, GSD Types I, II, and III have all been reported to be associated with PH. Most patients with PH complicating the course of GSD were in their second or third decade of life, suggesting that long-term metabolic abnormalities may contribute to the long latency of PH. [3] Endothelial dysfunction secondary to the metabolic disturbances of glucose has been speculated as a mechanism of PH. In our case, muscle weakness is one of the main features, including the skeletal and respiratory muscles, causing severely impaired pulmonary function and respiratory failure, which may lead to PH. Some suggested that smooth muscle cells in blood vessels might also be involved as another mechanism for PH. [4, 5] In conclusion, GSD-associated PH is rare with unclear etiology and/ or multifactorial factors. Respiratory muscle weakness and reduced pulmonary function may be the main factors for PH in GSD Type II.
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